DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Blauvelt A. et al
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Lancet (London, England) 2017;
389 10086 2287-2303
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.